Join us in Brisbane at our face-to-face NET Patient Education Forum this June. This is a wonderful opportunity to ask “Our Expert NET Clinicians” questions and gain information on current treatments and Clinical Trials.
When: Monday 17 June, 2024
Time: 5:30 pm – 8:30 pm local time
Where: Brisbane Convention Centre. Merivale St, South Brisbane
Cost: Free
RSVP: Monday 10 June, registration is essential for catering purposes.
There will be plenty of time for questions and discussion at the Forum and you are invited to submit any questions you would like addressed prior to the event. To submit questions or for any further information, please contact info@neuroendocrine.org.au
*Denotes mandatory field
Can’t make it to Launceston? Meet other NET Patients at Cancer Council Sandy Bay for the Live Stream. NET Patients and carers can still join in the Q&A from Sandy Bay. This is a wonderful opportunity to ask “Our Expert NET Clinicians” questions and gain information on current treatments and Clinical Trials.
When: Friday 27 October 2023
Time: 2:30 pm – 4:30 pm local time
Where: Southern Cancer Support Centre, Cancer Council Hobart, 15 Princes St. Sandy Bay
Cost: Free
RSVP: Tuesday 24th October, registration is essential for catering purposes.
There will be plenty of time for questions and discussion at the Forum and you are invited to submit any questions you would like addressed prior to the event. To submit questions or for any further information, please contact info@neuroendocrine.org.au
We look forward to seeing you there.
Agenda
| 2:30pm | Doors Open | Registration and light refreshments |
| 3:00pm | Meredith Cummins (CEO NeuroEndocrine Cancer Australia) | Welcome & NECA update: |
| 3:15pm | Dr Tomasz Block (Endocrinology Advanced Trainee) | Genetics and NETS |
| 3:35pm | Dr Jeremy Power (Medical Oncologist) | NETs and Treatment Options |
| 3:55pm | Yasmine Innocenti (Cancer Council Tas Supportive Care Coordinator) | Cancer Council Services |
| 4:10pm | Q&A | Led by Meredith Cummins |
| 4:30pm | Close |
Invited guest experts include:
Dr Mark Nalder
(Medical Oncologist)
Dr Mark Nalder is currently a Medical Oncologist at Royal Brisbane and Women’s Hospital (RBWH). He also has private practice at North-West Private Hospital in Everton Park. He has a strong interest in neuroendocrine tumours and is regularly involved in the neuroendocrine MDT at RBWH. He has a strong research interest, currently undertaking a PhD through the University of Queensland and has previously published the results of PRRT Lutate therapy in patients with neuroendocrine tumours in Queensland.
Dr Lorcan Ruane
(Fellow in Echocardiography – The Prince Charles Hospital)
Lorcan Ruane is a cardiologist with a special interest in Cardio-Oncology and Carcinoid Heart Disease. He is currently undertaking a sub-specialty fellowship in echocardiography at The Prince Charles Hospital and prior to this undertook physician and cardiology training at The Royal Brisbane and Women’s Hospital. Lorcan’s research work aims to improve our understanding of the effects of cancer, and its treatment, on the heart.
Meredith Cummins
(CEO – NeuroEndocrine Cancer Australia)
Meredith has been working at NeuroEndocrine Cancer Australia since February 2018 and has held the position of Project Officer / CRA & Telehealth Nurse prior to commencing the role of CEO in October 2022. Since commencing with NeuroEndocrine Cancer Australia Meredith has been fundamental in the development of PLANET Registry and Patient App, the NET Optimal Care Pathway, our fully accredited GP and Nurse Education Modules and the Living with NETs Program. She is actively involved in the Support Groups nationally and has coordinated and facilitated many Patient Education Forums across Australia.
Meredith is a highly driven and dedicated health professional who thrives on delivering world class care and support to cancer patients and enhancing the skills of other health professionals to deliver this care. She has been involved in Oncology for over 30 years in metropolitan, rural, international, public and private settings. She has been a key player instrumental in the commissioning and establishment of four private cancer care facilities in New South Wales.
Meredith has a wealth of experience in comprehensive cancer care, accreditation and licensing processes, governance (Board of Directors and Medical Advisory Committees), quality management systems, fundraising, liaison with pharmaceutical companies and Philanthropic groups and all aspects of practice management. She enjoys creating and developing dynamic teams so that cancer patients can benefit from Best Practice care and health professionals can develop skills and enhance their career pathways.
Meredith has a passion for developing and delivering world class cancer care and support to neuroendocrine patients across Australia.
Thank you to our sponsor
